Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: A cross-matched pilot investigation of the optimal daily dose and timing

Although it is widely accepted that patients, who are considered poor responders to in vitro fertilization (IVF) benefit from recombinant luteinizing hormone (rLH) supplementation during an in vitro fertilization cycle, particularly when gonadotropin-releasing hormone (GnRH) antagonist (ant) treatme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Med Rep
Main Authors: GIZZO, SALVATORE, ANDRISANI, ALESSANDRA, NOVENTA, MARCO, MANFÈ, SERENA, OLIVA, ALESSANDRA, GANGEMI, MICHELE, NARDELLI, GIOVANNI BATTISTA, AMBROSINI, GUIDO
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2015
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526099/
https://ncbi.nlm.nih.gov/pubmed/26059981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2015.3904
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados